No connection

Search Results

ARAY vs HYFT

ARAY
Accuray Incorporated
BEARISH
Price
$0.37
Market Cap
$44.0M
Sector
Healthcare
AI Confidence
85%
HYFT
MindWalk Holdings Corp.
BEARISH
Price
$1.07
Market Cap
$50.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ARAY
--
HYFT
--
Forward P/E
ARAY
-12.35
HYFT
--
P/B Ratio
ARAY
0.82
HYFT
4.68
P/S Ratio
ARAY
0.1
HYFT
1.78
EV/EBITDA
ARAY
-74.73
HYFT
-4.06

Profitability

Gross Margin
ARAY
27.85%
HYFT
57.19%
Operating Margin
ARAY
3.73%
HYFT
-88.36%
Profit Margin
ARAY
-8.15%
HYFT
-43.6%
ROE
ARAY
-70.32%
HYFT
-58.82%
ROA
ARAY
-1.18%
HYFT
-18.94%

Growth

Revenue Growth
ARAY
16.8%
HYFT
52.4%
Earnings Growth
ARAY
--
HYFT
--

Financial Health

Debt/Equity
ARAY
2.9
HYFT
0.24
Current Ratio
ARAY
1.47
HYFT
3.74
Quick Ratio
ARAY
0.6
HYFT
3.4

Dividends

Dividend Yield
ARAY
--
HYFT
--
Payout Ratio
ARAY
0.0%
HYFT
0.0%

AI Verdict

ARAY BEARISH

ARAY's Piotroski F-Score of 4/9 indicates weak financial health, with a critical debt-to-equity ratio of 2.90 and negative ROE of -70.32%, signaling significant operational and solvency concerns. Despite a 16.8% year-over-year revenue growth, the company remains unprofitable with a negative profit margin of -8.15% and erratic earnings performance, including a -650% YoY EPS decline. The stock trades at a deeply discounted price-to-sales of 0.10 and price-to-book of 0.82, but this reflects severe market skepticism due to persistent losses and high financial risk. Analysts have a target price of $2.52, implying a potential 580% upside, yet this is based on minimal coverage and no consensus, underscoring speculative risk. The lack of insider activity and technical bearishness further reinforce a high-risk profile.

Strengths
16.8% year-over-year revenue growth indicates top-line expansion in a competitive healthcare sector
Price-to-sales ratio of 0.10 suggests deep undervaluation relative to sales
Positive operating margin of 3.73% shows some operational efficiency despite net losses
Risks
Piotroski F-Score of 4/9 signals weak financial health and deteriorating fundamentals
Negative ROE (-70.32%) and ROA (-1.18%) indicate severe capital inefficiency and losses
Debt-to-equity ratio of 2.90 is dangerously high, especially for a loss-making firm
HYFT BEARISH

MindWalk Holdings Corp. (HYFT) exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While the company shows strong top-line revenue growth of 52.4% and maintains a healthy current ratio of 3.74, it is unable to translate this growth into profitability, with an operating margin of -88.36%. The stock is currently in a sharp technical downtrend, losing over 40% of its value in the last six months. Despite a high analyst target price of $4.00, the consistent failure to meet earnings estimates (0/4 beats) suggests a significant disconnect between analyst expectations and operational reality.

Strengths
Strong YoY revenue growth of 52.40%
Healthy liquidity with a current ratio of 3.74
Low leverage with a Debt/Equity ratio of 0.24
Risks
Critical financial health (Piotroski F-Score 1/9)
Severe lack of profitability with ROE at -58.82%
Consistent earnings misses (Average surprise -106.63% over last 4 quarters)

Compare Another Pair

ARAY vs HYFT: Head-to-Head Comparison

This page compares Accuray Incorporated (ARAY) and MindWalk Holdings Corp. (HYFT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile